| | Review PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study Erland Erdmann, John Dormandy, Robert Wilcox, Massimo Massi-Benedetti, and Bernard Charbonnel Vasc Health Risk Manag. 2007 August; 3(4): 355–370. PMCID: PMC2291341 Original Research Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy Roland Asmar, Juan Garcia-Puig, Philippe Gosse, Yuri A Karpov, Peter Wilhem De Leeuw, Dieter Magometschniggs, Lajos Matos, and Roland Schmieder Vasc Health Risk Manag. 2007 August; 3(4): 371–380. PMCID: PMC2291338 Arterial Stiffness and Pharmacological Interventions – The TRanscend Arterial stiffNess Substudy (TRANS study) Jirar Topouchian, Ramzi El Feghali, Bruno Pannier, Shuyu Wang, Feng Zhao, Karel Smetana, Koon Teo, and Roland Asmar Vasc Health Risk Manag. 2007 August; 3(4): 381–388. PMCID: PMC2291337 Validation of four automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension Jalil Belghazi, Ramzi N El Feghali, Thérèse Moussalem, Maya Rejdych, and Roland G Asmar Vasc Health Risk Manag. 2007 August; 3(4): 389–400. PMCID: PMC2291343 Effect of continuous cisternal cerebrospinal fluid drainage for patients with thin subarachnoid hemorrhage Yasunari Otawara, Kuniaki Ogasawara, Yoshitaka Kubo, Masayuki Sasoh, and Akira Ogawa Vasc Health Risk Manag. 2007 August; 3(4): 401–404. PMCID: PMC2291329 Increased tissue factor, MMP-8, and D-dimer expression in diabetic patients with unstable advanced carotid atherosclerosis Jerzy Krupinski, Marta M Turu, M Angels Font, Nesser Ahmed, Matthew Sullivan, Ana Luque, Francisco Rubio, Lina Badimon, and Mark Slevin Vasc Health Risk Manag. 2007 August; 3(4): 405–412. PMCID: PMC2291344 Occipital lobe infarctions are different Halvor Naess, Ulrikke Waje-Andreassen, and Lars Thomassen Vasc Health Risk Manag. 2007 August; 3(4): 413–415. PMCID: PMC2291333 Combined use of brain natriuretic peptide and C-reactive protein for predicting cardiovascular risk in outpatients with type 2 diabetes mellitus Toshihiro Tsuruda, Johji Kato, Takahiro Sumi, Kazuya Mishima, Hiroyuki Masuyama, Hiroyuki Nakao, Takuroh Imamura, Tanenao Eto, and Kazuo Kitamura Vasc Health Risk Manag. 2007 August; 3(4): 417–423. PMCID: PMC2291340 Reviews Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction Naylin Bissessor and Harvey White Vasc Health Risk Manag. 2007 August; 3(4): 425–430. PMCID: PMC2291334 Bisoprolol in the treatment of chronic heart failure Pascal de Groote, Pierre-Vladimir Ennezat, and Fréderic Mouquet Vasc Health Risk Manag. 2007 August; 3(4): 431–439. PMCID: PMC2291328 Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions Alaide Chieffo, Tiziana Claudia Aranzulla, and Antonio Colombo Vasc Health Risk Manag. 2007 August; 3(4): 441–451. PMCID: PMC2291332 Managing hypertension in diabetic patients – focus on trandolapril/verapamil combination Sanjib Kumar Sharma, Piero Ruggenenti, and Giuseppe Remuzzi Vasc Health Risk Manag. 2007 August; 3(4): 453–465. PMCID: PMC2291330 Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study Anja Vogt, Ursula Kassner, Ulrike Hostalek, and Elisabeth Steinhagen-Thiessen Vasc Health Risk Manag. 2007 August; 3(4): 467–479. PMCID: PMC2291331 Update on stents: Recent studies on the TAXUS® stent system in small vessels Shuzou Tanimoto, Joost Daemen, and Patrick W Serruys Vasc Health Risk Manag. 2007 August; 3(4): 481–490. PMCID: PMC2291327 Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease Sven-Olof Olofsson, Olov Wiklund, and Jan Borén Vasc Health Risk Manag. 2007 August; 3(4): 491–502. PMCID: PMC2291326 Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes John M Stafford and Tom Elasy Vasc Health Risk Manag. 2007 August; 3(4): 503–510. PMCID: PMC2291335 The burden of type 2 diabetes: strategies to prevent or delay onset Nayyar Iqbal Vasc Health Risk Manag. 2007 August; 3(4): 511–520. PMCID: PMC2291325 Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors José Tuñón, José Luis Martín-Ventura, Luis Miguel Blanco-Colio, Nieves Tarín, and Jesús Egido Vasc Health Risk Manag. 2007 August; 3(4): 521–526. PMCID: PMC2291342 Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors Geir E Tjønnfjord and Pål Andre Holme Vasc Health Risk Manag. 2007 August; 3(4): 527–531. PMCID: PMC2291336 Systematic Review Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients Ana T Rocha, Edison F Paiva, Arnaldo Lichtenstein, Rodolfo Milani, Jr, Cyrillo Cavalheiro-Filho, and Francisco H Maffei Vasc Health Risk Manag. 2007 August; 3(4): 533–553. PMCID: PMC2291339 |